5UY-27979-38664
3 vaccinations
2 coded responses
18 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 801 / CO
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Dose 1 — Pfizer-BioNTech
-
2021-03-30
Registered in v-safe
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-04
- 2021-04-05
- 2021-04-12
-
2021-04-19
Dose 2 — Pfizer-BioNTech
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-07-19
- 2021-10-18
-
2021-11-15
Dose 3 — Pfizer-BioNTech
-
2022-04-19
Survey response — 12 months, dose 2MedDRA: Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Benign breast tumor Food allergyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-21
- 2022-05-16
-
2022-11-15
Survey response — 12 months, dose 3MedDRA: Ectopic pregnancy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Ectopic pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-11-16
- 2022-11-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-19 | Unsuccessful | |
| 2022-11-15 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Symptoms: Benign breast tumor Food allergy
Release 12 — 12 months, dose 3
Symptoms: Ectopic pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ectopic pregnancy | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release